Expanded analyses of napoli-1: Phase 3 study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin, versus 5-fluorouracil and leucovorin, in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy.
暂无分享,去创建一个
G. Bodoky | D. Cunningham | E. Bayever | Chung-Pin Li | Li‐Tzong Chen | F. Braiteh | J. Blanc | R. Hubner | J. Siveke | G. Schwartsmann | T. Macarulla | C. Chiu | Y. Shan | Kyung-Hun Lee | D. D. Hoff | V. Moyo | A. Wang-Gillam | A. Dean | G. Jameson | B. Belanger